LearnGlossaryMarketStocksSuperinvestorsSign in

PFSA

Profusa, Inc. Common Stock

Healthcare · $2M market cap

Verdict

We can't put a fair value on PFSA right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.

Business quality

1 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth—?
Free cash flow growth—?
Return on invested capital76.9%✓

Follow PFSA

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Aug 21, 2026: no open-market purchases and 4 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

STOVER JACK E

Chief Executive Officer · 2026-08-21

J-Other

301,991 shares

STOVER JACK E

Chief Executive Officer · 2026-08-21

J-Other

32,018 shares

Knechtel Fred S.

Chief Financial Officer · 2026-08-21

J-Other

301,991 shares

Knechtel Fred S.

Chief Financial Officer · 2026-08-21

J-Other

54,323 shares

About Profusa, Inc. Common Stock

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works